Bright Minds Biosciences Inc.
Status: Publicly traded
Direct answer
Bright Minds Biosciences Inc. is publicly traded on NASDAQ under the ticker DRUG.
Bright Minds Biosciences Inc. is a preclinical biotechnology firm dedicated to creating serotonin-based therapies. Its primary goal is to enhance the well-being of individuals suffering from severe and life-altering conditions. The company's development pipeline includes selective agonists for the 5-HT2C, 5-HT2A, and combined 5-HT2C/A serotonin receptors, which are being explored for potential treatments in...
Can you invest in Bright Minds Biosciences Inc.?
Yes. Bright Minds Biosciences Inc. is publicly traded on NASDAQ under the ticker DRUG.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Bright Minds Biosciences Inc.
Detailed equity research is provided by MarketSnap.